Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

BHR Pharma Expands SyNAPSeŽ Trial into Thailand, China and Russia
BHR Pharma via Yahoo ^ | Jun 12, 2012 | NA

Posted on 06/19/2012 10:56:42 PM PDT by neverdem

Study Evaluating Intravenous Progesterone Formulation BHR-100 to Treat Traumatic Brain Injury Set to Complete in 2013

BHR Pharma's SyNAPSe® clinical trial is now enrolling patients suffering from severe traumatic brain injury (TBI) at 14 sites in Thailand, China and Russia. The trial currently has 153 participating sites (Level 1 and 2 trauma centers) worldwide.

The 500th of 1,180 patients needed to complete the global Phase III, multi-center trial was enrolled at the end of May in the United States.

SyNAPSe is evaluating the effectiveness of BHR-100, a...

--snip--

TBI is a serious public health problem that affects more than 1.7 million Americans each year. Despite significant efforts in more than 75 clinical trials over the past 20 years, there is still no approved treatment for TBI.

Previous research has shown progesterone exerts its neuroprotective effects by protecting or rebuilding the blood-brain barrier, decreasing development of cerebral edema (brain swelling), down-regulating the inflammatory cascade and limiting cellular necrosis and apoptosis (programmed cell death).

"Unfortunately, little can be done to reverse the initial brain damage caused by a TBI. Once a TBI occurs, medical treatment focuses on preventing further injury and promoting rehabilitation," said Dr. MacAllister. "BHR-100 is designed to protect brain cells from dying right after the injury, which may facilitate outcomes previously not thought to be possible."

Building on the SyNAPSe study of BHR-100 and promising research conducted by Emory University, BHR is also developing BHR-310, an intranasal progesterone powder. This nasal spray is being evaluated as a potential treatment that can be administered to wounded warriors or athletes with TBI quickly after injury on the battlefield or playing field. Preclinical studies of BHR-310 in rats and monkeys support the feasibility of a high-dose, rapidly absorbed intranasal progesterone product able to deliver clinically meaningful doses of progesterone to the brain.

(Excerpt) Read more at finance.yahoo.com ...


TOPICS: Culture/Society; Foreign Affairs; News/Current Events; Testing
KEYWORDS: bhr100; immunology; inflammation; progesterone; tbi
This makes sense. Pregnant females down regulate their immune systems to tolerate the fetus. Progesterone is elevated during pregnancy, so it could be the ticket.
1 posted on 06/19/2012 10:56:57 PM PDT by neverdem
[ Post Reply | Private Reply | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson